Literature DB >> 29130028

Sphingosine Kinases/Sphingosine 1-Phosphate Signaling in Hepatic Lipid Metabolism.

Eric K Kwong1, Xiaojiaoyang Li1, Phillip B Hylemon1, Huiping Zhou1.   

Abstract

The ever-increasing prevalence of metabolic diseases such as dyslipidemia and diabetes in the western world continues to be of great public health concern. Biologically active sphingolipids, such as sphingosine 1-phosphate (S1P) and ceramide, are important regulators of lipid metabolism. S1P not only directly functions as an active intracellular mediator, but also activates multiple signaling pathways via five transmembrane G-protein coupled receptors (GPCRs), S1PR1-5. S1P is exclusively formed by sphingosine kinases (SphKs). Two isoforms of SphKs, SphK1 and SphK2, have been identified. Recent identification of the conjugated bile acid-induced activation of S1PR2 as a key regulator of SphK2 opened new directions for both the sphingolipid and bile acid research fields. The role of SphKs/S1P-mediated signaling pathways in health and various human diseases has been extensively reviewed elsewhere. This review focuses on recent findings related to SphKs/S1P-medaited signaling pathways in regulating hepatic lipid metabolism.

Entities:  

Keywords:  G protein-coupled receptor; Hepatic lipid metabolism; Metabolic diseases; Sphingolipids; Sphingosine 1-phosphate; Sphingosine kinase

Year:  2017        PMID: 29130028      PMCID: PMC5678993          DOI: 10.1007/s40495-017-0093-2

Source DB:  PubMed          Journal:  Curr Pharmacol Rep        ISSN: 2198-641X


  94 in total

Review 1.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

2.  The S1P2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function.

Authors:  A John MacLennan; Shannon J Benner; Anastasia Andringa; Alicia H Chaves; Joanna L Rosing; Rachel Vesey; Adam M Karpman; Samantha A Cronier; Nancy Lee; Larry C Erway; Marian L Miller
Journal:  Hear Res       Date:  2006-08-30       Impact factor: 3.208

3.  Sphingosine kinase 2: a controversial role in arthritis.

Authors:  Tao Xu; Lin Li; Cheng Huang; Yunyun Peng; Jun Li
Journal:  Rheumatol Int       Date:  2013-07-24       Impact factor: 2.631

4.  Ceramide metabolism is affected by obesity and diabetes in human adipose tissue.

Authors:  A U Błachnio-Zabielska; M Pułka; M Baranowski; A Nikołajuk; P Zabielski; M Górska; J Górski
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

Review 5.  Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling.

Authors:  Michael Maceyka; Sheldon Milstien; Sarah Spiegel
Journal:  J Lipid Res       Date:  2008-11-05       Impact factor: 5.922

6.  Resistance of SHP-null mice to bile acid-induced liver damage.

Authors:  Li Wang; Yunqing Han; Chang-Soo Kim; Yoon-Kwang Lee; David D Moore
Journal:  J Biol Chem       Date:  2003-08-21       Impact factor: 5.157

Review 7.  Nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Vincent W-S Wong; Valerio Nobili; Christopher P Day; Silvia Sookoian; Jacquelyn J Maher; Elisabetta Bugianesi; Claude B Sirlin; Brent A Neuschwander-Tetri; Mary E Rinella
Journal:  Nat Rev Dis Primers       Date:  2015-12-17       Impact factor: 52.329

Review 8.  Sphingolipids and membrane biology as determined from genetic models.

Authors:  Raghavendra Pralhada Rao; Jairaj K Acharya
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-10-13       Impact factor: 3.072

9.  Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells.

Authors:  Xiwei Ding; Roongruedee Chaiteerakij; Catherine D Moser; Hassan Shaleh; Jeffrey Boakye; Gang Chen; Albert Ndzengue; Ying Li; Yanling Zhou; Shengbing Huang; Frank A Sinicrope; Xiaoping Zou; Melanie B Thomas; Charles D Smith; Lewis R Roberts
Journal:  Oncotarget       Date:  2016-04-12

10.  Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640.

Authors:  Clayton S Lewis; Christina Voelkel-Johnson; Charles D Smith
Journal:  Oncotarget       Date:  2016-09-13
View more
  9 in total

Review 1.  Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease.

Authors:  Eric K Kwong; Puneet Puri
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05

2.  Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American Liver Society/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021.

Authors:  Wen-Xing Ding; Hua Wang; Yuxia Zhang
Journal:  Liver Res       Date:  2022-01-29

3.  Sphingolipid metabolism as a marker of hepatotoxicity in drug-induced liver injury.

Authors:  Linhao Li; Hongbing Wang; Jace W Jones
Journal:  Prostaglandins Other Lipid Mediat       Date:  2020-09-30       Impact factor: 3.072

4.  Transforming Growth Factor β1 (TGF-β1) Appears to Promote Coronary Artery Disease by Upregulating Sphingosine Kinase 1 (SPHK1) and Further Upregulating Its Downstream TIMP-1.

Authors:  Shoudong Wang; Qing Zhang; Yingcui Wang; Beian You; Qingfeng Meng; Sen Zhang; Xuanlong Li; Zhiming Ge
Journal:  Med Sci Monit       Date:  2018-10-14

5.  Evaluation of sphingolipid metabolism on diabetic retinopathy.

Authors:  Ezgi Naz Ensari Delioğlu; Nagihan Uğurlu; Ebru Erdal; Soheil Malekghasemi; Nurullah Çağıl
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

6.  RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression.

Authors:  Yanyan Wang; Yun-Ling Tai; Grayson Way; Jing Zeng; Derrick Zhao; Lianyong Su; Xixian Jiang; Kaitlyn G Jackson; Xuan Wang; Emily C Gurley; Jinze Liu; Jinpeng Liu; Weidong Chen; Xiang-Yang Wang; Arun J Sanyal; Phillip B Hylemon; Huiping Zhou
Journal:  Cell Biosci       Date:  2022-10-12       Impact factor: 9.584

7.  miR-19a/b-3p promotes inflammation during cerebral ischemia/reperfusion injury via SIRT1/FoxO3/SPHK1 pathway.

Authors:  Feng Zhou; Yu-Kai Wang; Cheng-Guo Zhang; Bing-Yi Wu
Journal:  J Neuroinflammation       Date:  2021-05-29       Impact factor: 8.322

Review 8.  "Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer.

Authors:  Nahal Haddadi; Yiguang Lin; Ann M Simpson; Najah T Nassif; Eileen M McGowan
Journal:  Int J Mol Sci       Date:  2017-09-02       Impact factor: 5.923

9.  K27Q/K29Q mutations in sphingosine kinase 1 attenuate high-fat diet induced obesity and altered glucose homeostasis in mice.

Authors:  Jing Xie; Yong Shao; Jin Liu; Meilan Cui; Xiuxiao Xiao; Jingbo Gong; Binghua Xue; Qunwei Zhang; Xianwen Hu; Haifeng Duan
Journal:  Sci Rep       Date:  2020-11-18       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.